This inventor holds 1 USPTO granted patent. Top assignee: Virobay, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations of Kyle Elrod
Introduction
Kyle Elrod is an accomplished inventor based in Belmont, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic potential for various diseases. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Kyle Elrod holds a patent for "Substituted pyrazines that inhibit protease cathepsin S and HCV replication." This invention is directed to compounds that possess the dual property of acting as cathepsin S inhibitors while also inhibiting HCV replication. Such compounds are valuable in treating disease states that include hepatitis C, Alzheimer's disease, and autoimmune disorders. The patent also encompasses pharmaceutical compositions containing these compounds and the processes for preparing them.
Career Highlights
Kyle is currently associated with Virobay, Inc., where he continues to advance his research and development efforts. His innovative work has led to the creation of a patent that holds promise for improving treatment options for patients suffering from serious health conditions.
Collaborations
Kyle collaborates with talented professionals in his field, including Leslie Jean Holsinger and John O Link. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Kyle Elrod's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing significant health issues. His work not only showcases his inventive spirit but also highlights the importance of collaboration in advancing medical science.